Showing results (241-250 of 361) with videos related to
Sort By:
Pageof 37
Cancer|January 13, 2010
Physician factors associated with discussions about end-of-life careNancy L Keating, Mary Beth Landrum, Selwyn O Rogers, et al.Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|June 4, 2019
Adherence to human epidermal growth factor receptor-2 testing and adjuvant trastuzumab treatment guidelines in OntarioDeborah A Marshall, Ilia L Ferrusi, Maureen Trudeau, et al.Cloning and Stem Cells|January 27, 2005
Birth of African Wildcat cloned kittens born from domestic catsMartha C Gómez, C Earle Pope, Angelica Giraldo, et al.Family Medicine|July 13, 2013
Physician roles in the cancer-related follow-up care of cancer survivorsCarrie N Klabunde, Paul K J Han, Craig C Earle, et al.JAMA Network Open|February 28, 2022
Comparative Effectiveness and Safety of Pertuzumab and Trastuzumab Plus Chemotherapy vs Trastuzumab Plus Chemotherapy for Treatment of Metastatic Breast CancerWei Fang Dai, Jaclyn M Beca, Chenthila Nagamuthu, et al.BMC Health Services Research|September 3, 2010
Variation in use of surveillance colonoscopy among colorectal cancer survivors in the United StatesTalya Salz, Morris Weinberger, John Z Ayanian, et al.Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract|January 7, 2017
The Impact of Increasing Hospital Volume on 90-Day Postoperative Outcomes Following PancreaticoduodenectomyDaniel J Kagedan, Nik Goyert, Qing Li, et al.Clinical Colorectal Cancer|June 27, 2006
Efficacy of cetuximab after treatment with oral epidermal growth factor receptor tyrosine kinase inhibitor-based chemotherapy in metastatic colorectal cancerJeffrey A Meyerhardt, Denise Heseltine, Shuji Ogino, et al.Breast Cancer Research and Treatment|May 14, 2018
Impact of high-deductible insurance on adjuvant hormonal therapy use in breast cancerChristine Y Lu, Fang Zhang, Anita K Wagner, et al.Cancer|July 13, 2002
A phase II trial of gemcitabine in patients with advanced hepatocellular carcinomaCharles S Fuchs, Jeffrey W Clark, David P Ryan, et al.Pageof 37